Clinical Islet Transplantation Trial : NIDDK

Clinical Islet Transplantation Trial

Clinical Islet Transplantation Consortium (CIT)

The purpose of this consortium is to develop and implement a program of single- and/or multi-center clinical studies, accompanied by mechanistic studies, in islet transplantation with or without accompanying kidney transplantation, for the treatment of type 1 diabetes.


Research Resources to be Made Available to the Scientific Community:

  • The consortium's website will provide information for ongoing studies and sites for potential patient referral;
  • Specimens (in the future) including plasma/serum/blood cell samples from patients before and after islet transplantation and from immunologic and metabolic testing;
  • Data (in the future):
    • Phenotype data from recruited patients;
    • Specific protocols done by the Consortium;
    • Results from the multiple tests and observations done in association with the clinical studies;
    • Process data (e.g. records of shipments and aliquots) concerning the collection and storage of specimens.

For more information, contact Dr. Thomas Eggerman, Director, Islet Transplantation Clinical Trials Program.

Resources for Researchers

Clinical Research


Related Study Sections


See Also

Funding Opportunities

Funding for Special Communities


Related Reports

Related Organizations

Page last updated: January 26, 2009

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation